Jointown Pharmaceutical Group Co Ltd Asset Resilience Ratio
Jointown Pharmaceutical Group Co Ltd asset resilience ratio. Jointown Pharmaceutical Group Co Ltd (600998) has an Asset Resilience Ratio of 0.08% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 600998 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Jointown Pharmaceutical Group Co Ltd (2012–2024)
Asset resilience ratio of Jointown Pharmaceutical Group Co Ltd from 2012 to 2024. This chart shows how Jointown Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. Read Jointown Pharmaceutical Group Co Ltd (600998) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Jointown Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Jointown Pharmaceutical Group Co Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥84.52 Million | 0.08% |
| Total Liquid Assets | CN¥84.52 Million | 0.08% |
Asset Resilience Insights
- Limited Liquidity: Jointown Pharmaceutical Group Co Ltd maintains only 0.08% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Jointown Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio
Compare Jointown Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
SINOPHARM GROUP 1/5/O.N.
F:X2S1 |
Medical Distribution | 0.00% |
|
Selcuk Ecza Deposu Ticaret ve Sanayi AS
IS:SELEC |
Medical Distribution | 7.12% |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368 |
Medical Distribution | 1.77% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
Jointown Pharmaceutical Group Co Ltd Asset Resilience Ratio by Year (2012–2024)
Jointown Pharmaceutical Group Co Ltd asset resilience ratio by year from 2012 to 2024. The table below shows the annual Asset Resilience Ratio data for Jointown Pharmaceutical Group Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.95% | CN¥972.34 Million ≈ $142.28 Million |
CN¥102.40 Billion ≈ $14.98 Billion |
+0.85pp |
| 2023-12-31 | 0.10% | CN¥90.03 Million ≈ $13.17 Million |
CN¥92.79 Billion ≈ $13.58 Billion |
-0.25pp |
| 2022-12-31 | 0.35% | CN¥319.72 Million ≈ $46.78 Million |
CN¥92.27 Billion ≈ $13.50 Billion |
-3.84pp |
| 2021-12-31 | 4.19% | CN¥3.60 Billion ≈ $526.38 Million |
CN¥85.94 Billion ≈ $12.58 Billion |
+4.17pp |
| 2020-12-31 | 0.02% | CN¥15.31 Million ≈ $2.24 Million |
CN¥80.82 Billion ≈ $11.83 Billion |
+0.02pp |
| 2018-12-31 | 0.00% | CN¥967.43K ≈ $141.57K |
CN¥66.67 Billion ≈ $9.76 Billion |
-0.02pp |
| 2016-12-31 | 0.02% | CN¥7.03 Million ≈ $1.03 Million |
CN¥38.73 Billion ≈ $5.67 Billion |
0.00pp |
| 2013-12-31 | 0.02% | CN¥3.99 Million ≈ $584.42K |
CN¥18.60 Billion ≈ $2.72 Billion |
-0.03pp |
| 2012-12-31 | 0.05% | CN¥8.04 Million ≈ $1.18 Million |
CN¥14.80 Billion ≈ $2.17 Billion |
-- |
About Jointown Pharmaceutical Group Co Ltd
Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added serv… Read more